Literature DB >> 12684812

Human experimental exposure to N-methyl-2-pyrrolidone (NMP): toxicokinetics of NMP, 5-hydroxy- N-methyl-2-pyrrolidone, N-methylsuccinimide and 2-hydroxy- N-methylsuccinimide (2-HMSI), and biological monitoring using 2-HMSI as a biomarker.

B A G Jönsson1, B Akesson.   

Abstract

OBJECTIVE: N-methyl-2-pyrrolidone (NMP) is a strong and selective organic solvent with an extensive and increasing use. It has been reported to be a compound that is toxic to the reproductive system. The aim of this study was to evaluate toxicokinetics parameters for NMP and its metabolites, 5-hydroxy- N-methyl-2- pyrrolidone (5-HNMP), N-methylsuccinimide (MSI) and 2-hydroxy- N-methylsuccinimide (2-HMSI), and to develop a method for biological monitoring of NMP exposure that uses 2-HMSI as a biomarker.
METHODS: Six healthy, male volunteers were exposed to NMP in an exposure chamber for 8 h at concentrations of 10, 25 and 50 mg/m(3). In addition, three of the subjects were exposed a second time at 50 mg/m(3). Air levels were monitored by Amberlite XAD-7 sampling and gas chromatography (GC) analysis. Levels of NMP and the metabolites in plasma and urine were analysed by GC or GC with mass spectrometry detection.
RESULTS: The concentration of 2-HMSI in plasma and urine rose during exposure and reached a peak approximately 15 h after the end of exposure. It then decayed according to a one-compartment model with a half-time of about 18 h. There were very close correlations between the NMP air levels, on the one hand, and concentrations of 2-HMSI in plasma (r=0.98) and creatinine-adjusted urinary 2-HMSI levels (r=0.96), on the other. The renal clearances were 0.13, 1.4, 0.12 and 1.2 l/h for NMP, 5-HNMP, MSI and 2-HMSI, respectively. The total clearances were 11.4, 3.2, 8.5 and 1.1 l/h for NMP, 5-HNMP, MSI and 2-HMSI, respectively. The apparent volumes of distribution were 41, 28, 120 and 28 l for NMP, 5-HNMP, MSI and 2-HMSI, respectively.
CONCLUSIONS: Toxicokinetics parameters for NMP, 5-HNMP, MSI and 2-HMSI have been estimated. Furthermore, 2-HMSI is applicable as a biomarker of exposure to NMP, and the levels in plasma and urine may be used to indicate an exposure over three days.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684812     DOI: 10.1007/s00420-003-0438-5

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  19 in total

1.  Determination of 5-hydroxy-N-methylpyrrolidone and 2-hydroxy-N-methylsuccinimide in human urine.

Authors:  B A Jönsson; B Akesson
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1997-07-04

2.  N-methylsuccinimide in plasma and urine as a biomarker of exposure to N-methyl-2-pyrrolidone.

Authors:  B A Jönsson; B Akesson
Journal:  Int Arch Occup Environ Health       Date:  2001-05       Impact factor: 3.015

3.  Permeability of commercial solvents through living human skin.

Authors:  C Ursin; C M Hansen; J W Van Dyk; P O Jensen; I J Christensen; J Ebbehoej
Journal:  Am Ind Hyg Assoc J       Date:  1995-07

4.  Effects of prenatal exposure to N-methylpyrrolidone on postnatal development and behavior in rats.

Authors:  U Hass; S P Lund; J Elsner
Journal:  Neurotoxicol Teratol       Date:  1994 May-Jun       Impact factor: 3.763

5.  Major metabolic pathway for N-methyl-2-pyrrolidone in humans.

Authors:  B Akesson; B A Jönsson
Journal:  Drug Metab Dispos       Date:  1997-02       Impact factor: 3.922

6.  Percutaneous absorption of co-administered N-methyl-2-[14C]pyrrolidinone and 2-[14C]pyrrolidinone in the rat.

Authors:  I Midgley; A J Hood; L F Chasseaud; C J Brindley; S Baughman; G Allan
Journal:  Food Chem Toxicol       Date:  1992-01       Impact factor: 6.023

7.  1-Methyl-2-pyrrolidone (NMP): reproductive and developmental toxicity study by inhalation in the rat.

Authors:  H M Solomon; B A Burgess; G L Kennedy; R E Staples
Journal:  Drug Chem Toxicol       Date:  1995-11       Impact factor: 3.356

8.  Ethosuximide in epileptic women during pregnancy and lactation period. Placental transfer, serum concentrations in nursed infants and clinical status.

Authors:  W Kuhnz; S Koch; S Jakob; A Hartmann; H Helge; H Nau
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

9.  Teratogenicity study of N-methylpyrrolidone after dermal application to Sprague-Dawley rats.

Authors:  P J Becci; M J Knickerbocker; E L Reagan; R A Parent; L W Burnette
Journal:  Fundam Appl Toxicol       Date:  1982 Mar-Apr

10.  Dermal exposure to aqueous solutions of N-methyl pyrrolidone.

Authors:  Peter Akrill; John Cocker; Steve Dixon
Journal:  Toxicol Lett       Date:  2002-08-05       Impact factor: 4.372

View more
  2 in total

1.  Biological monitoring and health effects of low-level exposure to N-methyl-2-pyrrolidone: a cross-sectional study.

Authors:  Vincent Haufroid; Veronika K Jaeger; Stefan Jeggli; Rolf Eisenegger; Alfred Bernard; Drita Friedli; Dominique Lison; Philipp Hotz
Journal:  Int Arch Occup Environ Health       Date:  2014-08       Impact factor: 3.015

2.  Influence of Organic Solvents on Secondary Brain Damage after Experimental Traumatic Brain Injury.

Authors:  Johannes Walter; Julian Schwarting; Nikolaus Plesnila; Nicole A Terpolilli
Journal:  Neurotrauma Rep       Date:  2020-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.